NCT02080377View on ClinicalTrials.gov

A Feasibility Study Looking at the Use of Glibenclamide and metfoRmin Versus stAndard Care in gEstational diabeteS

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

March 31, 2016

Conditions

PregnancyGestational Diabetes

Interventions

DRUG

Glibenclamide

DRUG

Insulin

Trial Locations (5)

Unknown

Queen Elizabeth Hospital, Glasgow

St Johns Hospital, Livingston

G31 2ER

Princess Royal Infirmary, Glasgow

EH16 4SA

Simpson Centre for Reproductive Health, Royal Infirmary Hospital, Edinburgh, Edinburgh

EH4 2XU

Western General Hospital, Edinburgh

All Listed Sponsors

collaborator

Chief Scientist Office of the Scottish Government

OTHER_GOV

lead

University of Edinburgh

OTHER

NCT02080377 - A Feasibility Study Looking at the Use of Glibenclamide and metfoRmin Versus stAndard Care in gEstational diabeteS | Biotech Hunter | Biotech Hunter